Form 4: Establishment Labs Holdings Inc. Executive Filippo Caldini Receives Stock Awards

Filippo Caldini, President of Establishment Labs Holdings Inc., was granted stock units and options under the company's 2018 Equity Incentive Plan.

Summary

• On August 20, 2024, Filippo Caldini, President of Establishment Labs Holdings Inc., received 9,078 common shares and options to purchase 17,910 common shares.
• The stock units were awarded under the Issuer's 2018 Equity Incentive Plan.
• One-fourth of the shares subject to the stock unit award will vest on August 20, 2025, and annually thereafter, contingent upon Caldini's continued service.
• Similarly, one-fourth of the shares subject to the option will vest on August 20, 2025, and annually thereafter, contingent upon Caldini's continued service.
• The exercise price for the stock options is $44.06.
• Rajbir S. Denhoy, Chief Financial Officer, signed the report on August 27, 2024, via power of attorney.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of equity is a positive sign of aligning management interests with shareholders, but it's a routine event.

Positives

• The equity awards align the executive's interests with those of the shareholders, incentivizing continued service and performance.
• The vesting schedule encourages long-term commitment from the executive.

Risks

• The value of the stock units and options is dependent on the future performance of Establishment Labs Holdings Inc.'s stock.
• If Caldini ceases to be a service provider, the unvested portions of the awards will be forfeited.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects, but the equity awards suggest an expectation of continued growth and value creation.

Industry Context

Equity compensation is a common practice in the medical technology industry to attract, retain, and incentivize key executives. The specific terms of the grant, such as the vesting schedule and exercise price, are tailored to the individual and the company's performance goals.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the medical device industry.
• Companies like Intuitive Surgical and Stryker also utilize equity-based compensation to align executive incentives with shareholder value.
• The vesting schedule of one-fourth annually is a typical arrangement, similar to those found in executive compensation plans at Medtronic and Boston Scientific.

Stakeholder Impact

• Shareholders may view the equity awards positively as they align management's interests with the company's long-term success.
• Employees may see the awards as a sign of the company's commitment to its leadership team.

Key Dates